When AI designs a drug, who gets the credit?
Newsvia MIT Technology Review

When AI designs a drug, who gets the credit?

When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press r

1 min read
Originally reported byMIT Technology Review
Share:

Source: Based on reporting by MIT Technology Review. Read the full article for complete details. When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform.


Published August 21, 2026 | Source: MIT Technology Review

Want the complete story? Read the full article at the original source.

Read Full Article on MIT Technology Review

Stay in the loop

Get the latest tech news and AI insights delivered to your inbox. No spam, unsubscribe anytime.

T

TechVeb Team

Your trusted source for the latest in technology, AI innovations, and digital trends. We bring you in-depth analysis, expert reviews, and comprehensive guides.

Learn more about us →

More ai News